Low Microbiota Diversity
1. Root Cause Overview
Gut microbiome diversity — measured by alpha diversity (species richness within an individual) and beta diversity (variation between individuals) — is a key indicator of gut health and systemic resilience. Low microbiome diversity is associated with obesity, type 2 diabetes, IBD, autoimmune disease, mental health disorders, and reduced immune function. The Western diet (low fibre, high processed food), antibiotic overuse, C-section birth, formula feeding, and sedentary lifestyle are primary drivers of reduced diversity. Restoration requires a multi-pronged approach: dietary fibre diversity, targeted probiotics, and lifestyle modification.
2. Common Signs & Symptoms
- Recurrent GI symptoms: bloating, irregular bowel habits
- Food intolerances (multiple, worsening over time)
- Recurrent infections and poor immune resilience
- Mood disturbances: anxiety, depression (gut-brain axis)
- Fatigue and low energy
- Skin conditions: eczema, psoriasis, acne
- Metabolic dysfunction: weight gain, insulin resistance
- Low short-chain fatty acid production on stool testing
- Low microbiome diversity on sequencing (Gut Zoomer, GI Effects)
- History of multiple antibiotic courses
3. Labs to Consider
CBC/CMP, stool testing when available, inflammatory markers (hs-CRP), metabolic markers.
Choose the lab option based on what you want to assess within this root cause.
Gut Zoomer
Vibrant Wellness
4. Clinical Priorities
Use a broad lens when supporting microbiome diversity, considering fibre intake, plant variety, prior antibiotic exposure, pathogen burden, motility, stress, sleep, exercise, and overall dietary pattern. Increasing plant diversity is often helpful, but the pace and sequence should be individualised based on tolerance and whether dysbiosis, infection, or SIBO are present. Introduce fermented foods and probiotics gradually as appropriate, while minimising unnecessary antibiotic exposure.
Where to Start: Top 2 Supplements
The most direct way to re-inoculate the gut with beneficial bacteria. Multi-strain formulas provide broader colonisation across different gut niches. Meta-analysis confirms improvement in IBS symptoms, gut permeability, and microbiome composition. Use as a foundation while building dietary diversity.
Probiotics without prebiotics have limited long-term colonisation. Prebiotic fibres selectively feed Bifidobacterium, Lactobacillus, and Akkermansia — the keystone species of a healthy microbiome. Synbiotic use (probiotic + prebiotic together) produces significantly greater diversity gains than either alone.
5. Diet Strategy
The 'Diversity Diet': aim for 30+ different plant foods per week (vegetables, fruits, legumes, whole grains, nuts, seeds, herbs, spices). Each plant food feeds different microbial species. Include prebiotic-rich foods daily: garlic, onions, leeks, asparagus, Jerusalem artichoke, green bananas, oats. Introduce fermented foods gradually: kefir, yogurt, sauerkraut, kimchi, kombucha, miso, tempeh. Minimise ultra-processed foods, artificial sweeteners, and emulsifiers — all reduce microbiome diversity.
6. Lifestyle Strategy
Regular aerobic exercise independently increases microbiome diversity (particularly Akkermansia and Bifidobacterium species). Spend time in nature and with animals — environmental microbial exposure enriches the microbiome. Avoid unnecessary antibiotics. Manage stress — chronic stress reduces Lactobacillus and Bifidobacterium species. Prioritise sleep — circadian disruption impairs microbiome composition. Breastfeeding and vaginal birth support early microbiome diversity.
7. Supplement Strategy
Full supplement list below. See Section 4 (Clinical Priorities) for the recommended Top 2 starting supplements. Add additional supplements based on lab results and clinical response at 4–6 week reassessment.
| Supplement | Dosage | Indication | Evidence | Key Results | Example |
|---|---|---|---|---|---|
| Multi-strain Probiotic (Lactobacillus + Bifidobacterium blend) [1] Transient bloating in first 1–2 weeks; avoid in immunocompromised without physician oversight | 25–100 billion CFU/day (multi-strain, 8–12 strains) | Microbiome restoration; diversity support; gut barrier and immune function | Meta-analysis of RCTs | Significant improvement in IBS symptoms, gut permeability, and microbiome composition; increased diversity | Klaire Labs Ther-Biotic Complete |
| Prebiotic Fibre Blend (FOS + Inulin + Partially Hydrolysed Guar Gum) [2] Gas and bloating initially — build up slowly; avoid in active IBD flare | 5–10 g/day (build up gradually to avoid gas) | Selective feeding of beneficial bacteria (Bifidobacterium, Lactobacillus, Akkermansia); SCFA production | RCT and mechanistic studies | Significantly increased Bifidobacterium and Lactobacillus counts; improved SCFA production; reduced gut permeability | Thorne FiberMend |
| Akkermansia muciniphila (pasteurised) [3] Generally well tolerated; mild GI adjustment initially | 100 million CFU/day (pasteurised form) | Gut barrier integrity; mucin layer support; metabolic health; microbiome diversity anchor | RCT (3 months) | Pasteurised Akkermansia improved gut barrier, insulin sensitivity, and metabolic markers; safe and well tolerated | Pendulum Akkermansia |
| Spore-based Probiotic (Bacillus coagulans + Bacillus subtilis + Bacillus clausii) [4] Generally well tolerated; can be taken with antibiotics (spore-forming, antibiotic-resistant) | 2–4 billion spores/day | Microbiome diversity; antibiotic-resistant probiotic; SCFA production; immune modulation | RCT | Significantly increased microbiome diversity; improved gut barrier markers; reduced GI symptoms | Just Thrive Probiotic |
| Postbiotic (Sodium Butyrate, enteric-coated) [5] Mild GI discomfort initially; generally well tolerated | 300–600 mg/day | Colonocyte fuel; tight junction support; anti-inflammatory SCFA; microbiome diversity support | Animal and human studies | Improved colonocyte energy metabolism; reduced gut permeability; supported microbiome diversity | BodyBio Butyrate |
| Polyphenol Complex (Resveratrol + Quercetin + Grape Seed Extract) [6] Generally well tolerated; resveratrol may interact with anticoagulants | Per label (typically 200–500 mg total polyphenols/day) | Prebiotic-like effect on microbiome; Akkermansia and Bifidobacterium enrichment; anti-inflammatory | RCT and mechanistic studies | Polyphenols selectively increased beneficial bacteria (Akkermansia, Bifidobacterium); reduced gut inflammation | Pure Encapsulations Polyphenol Nutrients |
8. Safety Notes
Probiotic supplementation in immunocompromised patients (HIV, transplant recipients, active cancer treatment) requires physician oversight — rare cases of bacteraemia have been reported. High-dose prebiotic fibre can cause significant GI symptoms in patients with SIBO — address SIBO first. Akkermansia supplementation is a relatively new intervention — long-term safety data beyond 3 months is limited. Always prioritise dietary fibre diversity as the primary microbiome intervention.
9. Citations & References
- [1]Multi-strain Probiotic (Lactobacillus + Bifidobacterium blend)Ford AC, Quigley EMM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014;109(10):1547–1561.View source
- [2]Prebiotic Fibre Blend (FOS + Inulin + Partially Hydrolysed Guar Gum)Roberfroid M, Gibson GR, Hoyles L, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr. 2010;104(Suppl 2):S1–S63.View source
- [3]Akkermansia muciniphila (pasteurised)Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096–1103.View source
- [4]Spore-based Probiotic (Bacillus coagulans + Bacillus subtilis + Bacillus clausii)Majeed M, Nagabhushanam K, Natarajan S, et al. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant irritable bowel syndrome: a double blind randomized placebo controlled pilot clinical study. Nutr J. 2016;15(1):21.View source
- [5]Postbiotic (Sodium Butyrate, enteric-coated)Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009;139(9):1619–1625.View source
- [6]Polyphenol Complex (Resveratrol + Quercetin + Grape Seed Extract)Dueñas M, Muñoz-González I, Cueva C, et al. A survey of modulation of gut microbiota by dietary polyphenols. Biomed Res Int. 2015;2015:850902.View source
Ask AI About This Protocol
Related Mini-Training
12:18Functional Gastroenterology Quick Start
9:47SIBO: Causes, Testing & Treatment
10:15Anti-Inflammatory Nutrition